We are live on ! Find out more
ANIK icon

Anika Therapeutics

146 hedge funds and large institutions have $542M invested in Anika Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 48 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,634% more call options, than puts

Call options by funds: $20.8M | Put options by funds: $762K

10% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 48

2.33% less ownership

Funds ownership: 95.22%92.89% (-2.3%)

11% less funds holding

Funds holding: 164146 (-18)

12% less capital invested

Capital invested by funds: $613M → $542M (-$70.7M)

52% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 33

Holders
146
Holders Change
-18
Holders Change %
-10.98%
% of All Funds
2.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
53
Reduced
48
Closed
33
Calls
$20.8M
Puts
$762K
Net Calls
+$20.1M
Net Calls Change
-$2.13M
Name Holding Trade Value Shares
Change
Change in
Stake
AWM
76
Avior Wealth Management
Nebraska
$543K +$9.56K +252 +2%
Canada Life
77
Canada Life
Manitoba, Canada
$525K -$39.8K -1,048 -8%
New York State Common Retirement Fund
78
New York State Common Retirement Fund
New York
$506K
CA
79
CSM Advisors
Pennsylvania
$481K +$448K +11,800 New
Thrivent Financial for Lutherans
80
Thrivent Financial for Lutherans
Minnesota
$480K -$303 -8 -0.1%
COPPSERS
81
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$451K +$1.48K +39 +0.4%
RA
82
Royce & Associates
New York
$438K -$124K -3,271 -23%
TPSF
83
Texas Permanent School Fund
Texas
$437K -$26.9K -708 -6%
Jane Street
84
Jane Street
New York
$404K +$376K +9,915 New
Wells Fargo
85
Wells Fargo
California
$400K -$7.06M -186,065 -95%
SOADOR
86
State of Alaska Department of Revenue
Alaska
$396K -$50.8K -1,340 -12%
BF
87
BOK Financial
Oklahoma
$392K
State Board of Administration of Florida Retirement System
88
State Board of Administration of Florida Retirement System
Florida
$368K -$11.4K -300 -3%
SAM
89
Shell Asset Management
Netherlands
$364K +$194K +5,117 +135%
State of Tennessee, Department of Treasury
90
State of Tennessee, Department of Treasury
Tennessee
$356K +$14.6K +384 +5%
Susquehanna International Group
91
Susquehanna International Group
Pennsylvania
$346K +$151K +3,989 +89%
Manulife (Manufacturers Life Insurance)
92
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$338K -$6.94K -183 -2%
BNP Paribas Financial Markets
93
BNP Paribas Financial Markets
France
$327K +$207K +5,467 +214%
MIM
94
MetLife Investment Management
New Jersey
$289K
T. Rowe Price Associates
95
T. Rowe Price Associates
Maryland
$265K -$645 -17 -0.3%
LSERS
96
Louisiana State Employees Retirement System
Louisiana
$265K
JP Morgan Chase
97
JP Morgan Chase
New York
$259K -$99.7K -2,628 -29%
ZCM
98
Zebra Capital Management
Connecticut
$247K +$229K +6,044 New
Squarepoint
99
Squarepoint
New York
$239K +$18.5K +489 +9%
OPERF
100
Oregon Public Employees Retirement Fund
Oregon
$237K +$3.79K +100 +2%

ANIK Hedge Fund Activity: Q1 2021 in Review

146 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2021, worth a combined $542M — down 12% from $613M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of ANIK and 16 opened new positions — a net loss of 17 holders — while 48 trimmed existing stakes and 53 added.

The largest buyer was Morgan Stanley, adding an estimated $21.1M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $33.1M sold.

  • 146 institutional investors held Anika Therapeutics (ANIK) as of Q1 2021, down from 164 in Q4 2020.
  • Funds reported $542M of Anika Therapeutics stock for Q1 2021, down 12% quarter-over-quarter.
  • 16 funds opened new Anika Therapeutics positions in Q1 2021 and 33 closed out, a net change of -17 holders.
  • The largest Anika Therapeutics buyer in Q1 2021 was Morgan Stanley, an estimated $21.1M added.
  • The largest Anika Therapeutics seller in Q1 2021 was Avidity Partners Management, an estimated $33.1M sold.

Based on aggregated 13F filings for Q1 2021.